Jenny Worthington
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 18
- Cancer, Lipids, and Metabolism 9
- Obstetrics and Gynecology top 5%
- Reproductive Medicine top 5%
- Biotechnology top 5%
- Cancer Research and Treatments 7
- Aquatic Science top 5%
-
- Prostate Cancer Treatment and Research 15
-
- Ubiquitin and proteasome pathways 8
- RNA Interference and Gene Delivery 5
-
- Virus-based gene therapy research 4
-
- Nitric Oxide and Endothelin Effects 4
- Co-authors
- Tracy RobsonHelen O. McCarthyStephanie McKeownDavid G. HirstJohn F. TimmsS. R. McKeownDeborah J. GersellDennis M. Balfe
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Jenny Worthington
57 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 325
- Obstetrics and Gynecology 167
- Reproductive Medicine 171
- Biotechnology 102
- Aquatic Science 65
Countries citing papers authored by Jenny Worthington
This map shows the geographic impact of Jenny Worthington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Worthington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Worthington more than expected).
Fields of papers citing papers by Jenny Worthington
This network shows the impact of papers produced by Jenny Worthington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Worthington. The network helps show where Jenny Worthington may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jenny Worthington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 10 | |
| 4 | 2020 | 69 | |
| 5 | 2019 | 39 | |
| 6 | 2017 | 0 | |
| 7 | 2016 | 23 | |
| 8 | Targeting hypoxic prostate tumours using the novel hypoxia-activated prodrug OCT1002 inhibits expression of genes associated with malignant progression | 2016 | 1 |
| 9 | 2016 | 30 | |
| 10 | 2015 | 16 | |
| 11 | 2014 | 28 | |
| 12 | 2012 | 37 | |
| 13 | 2012 | 36 | |
| 14 | 2011 | 44 | |
| 15 | 2011 | 34 | |
| 16 | 2010 | 22 | |
| 17 | 2008 | 27 | |
| 18 | 2008 | 5 | |
| 19 | 2004 | 45 | |
| 20 | 1993 | 27 |
About Jenny Worthington
Jenny Worthington is a scholar working on Cancer Research, Biotechnology, Reproductive Medicine, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 58 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (18 papers), Prostate Cancer Treatment and Research (15 papers), Cancer, Lipids, and Metabolism (9 papers), Ubiquitin and proteasome pathways (8 papers), Cancer Research and Treatments (7 papers), RNA Interference and Gene Delivery (5 papers), Virus-based gene therapy research (4 papers) and Nitric Oxide and Endothelin Effects (4 papers). The work is most often cited by research in Cancer Research (325 citations), Obstetrics and Gynecology (167 citations), Reproductive Medicine (171 citations), Biotechnology (102 citations) and Aquatic Science (65 citations). Jenny Worthington has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Tracy Robson, Helen O. McCarthy, Stephanie McKeown, David G. Hirst, John F. Timms, S. R. McKeown, Deborah J. Gersell, Dennis M. Balfe, Marilyn J. Siegel and Sarah Hotchkiss. Their work appears in journals such as Gene Therapy, Cancer Research, The Journal of Gene Medicine, British Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.